ALTECH CHEMICALS – Building a low cost plant to supply key materials used in the production of new technologies
I recently caught up with Altech Chemicals CFO, Shane Volk to learn more about how this company is
Analyst Research
Analyst Research
FAMILY ZONE CYBER SAFETY – Protecting children in the digital world
HiTech Group has delivered record profits in each of the past three years and looks to be heading
Analyst Research
HITECH GROUP – High growth, very strong cash generating profile paying a fully franked dividend
HiTech Group has delivered record profits in each of the past three years and looks to be heading
Analyst Research
INTELLIHR – With domestic growth accelerating, the international market beckons
IntelliHR listed on the ASX in January 2018 to commercialise its digital human resources data management SaaS platform.
Meeting Notes
Wingara AG Limited (WNR) FY 2019 Result
Wingara Ag is building an end-to-end export-oriented agricultural infrastructure platform capable of scaling industrial processing and marketing capacity
Analyst Research
IDENTITII – Enabling banks to adapt legacy systems to new technologies so as to meet increasing global regulatory pressures
Identitii listed on the ASX in October last year after four years of development work on a technology
Analyst Research
Whitehawk – Assessing SME cyber risk in deep and complex supply chains
US based WhiteHawk, who listed in the ASX in January 2018, is an expert in cybersecurity risk profiling
Analyst Research
Selfwealth – A compelling, differentiated proposition in the online broker market
SelfWealth is Australia’s only flat rate stockbroker. Since listing on the ASX in November 2017, the company has
Meeting Notes
IODM – Automated solution for managing accounts receivable
Since listing on the ASX in July 2016, IODM has kept a low profile whilst it commercialised its
Meeting Notes
Novita Healthcare – On the ground floor in the emerging market for digital therapeutics; the next wave in healthcare
Novita Healthcare launched its digital therapy application focussed on treating childhood attention in mid-2018 and over the past